FDA approves Roche's Herceptin for gastric cancer

10/20/2010 | Reuters

The FDA has approved the use of Roche Holding's Herceptin with chemotherapy for advanced HER2-positive stomach cancer. The approval was based on a pivotal study showing that the drug combination extended survival compared with chemotherapy alone.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT